LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX)

CUSIP: 528872302

Q3 2025 13F Holders as of 30 Sep 2025

Holder snapshot 7 signals
Share change
-1,127,208
Put/Call ratio
11%
SEC-reported price per share
$1.35
Number of holders
121
Value change
-$1,045,992
Number of buys
44
Open additional details 1 more signal available
Number of sells
57
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
444,955,931

Security key

528872302

Report period

Q3 2025

Institutions

121

Top holders

10

Ownership snapshot

Top reported holders of LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Siren, L.L.C.
Disclosed value leader
Artal Group S.A.
Comparable rows
0/15
Latest evidence
30 Jun 2025
3/4/5 13F Highest disclosed value: $129,371,457 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Artal Group S.A. has the largest disclosed position value at $129.37M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Artal Group S.A.'s linked filing trail.
Disclosed position value Top 5
Siren, L.L.C. $92.76M
Invus US Partners LLC $6.09M
Artal Group S.A. $129.37M
FMR LLC $36.07M
VANGUARD GROUP INC $8.37M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Siren, L.L.C.
3/4/5 13F
Director, 10%+ Owner · Individual
—
denominator unverified
$92,755,045
35,402,689 shares
— 25 Jul 2024
Invus US Partners LLC
3/4/5
Director, 10%+ Owner
—
denominator unverified
$6,090,969
5,782,749 shares
— 05 Aug 2022
Artal Group S.A.
13F
Company
13F
—
denominator unverified
$129,371,457
136,180,481 shares
— 30 Jun 2025
FMR LLC
13F
Company
13F
—
denominator unverified
$36,066,667
38,137,535 shares
— 30 Jun 2025
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$8,373,080
8,851,036 shares
— 30 Jun 2025
Schonfeld Strategic Advisors LLC
13F
Company
13F
—
denominator unverified
$4,327,663
4,576,152 shares
— 30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
121
Shares
255,139,258
Rows available
121
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
121
Q3 2025 holders
121
Holder diff
0
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .